Tempest Therapeutics
Price & Volume
Stats
See moreOpen | $2.21 |
Previous Close | $2.25 |
Day Range | $2.11-$2.21 |
52W Range | $1.50-$12.23 |
Market Cap | $30.6M |
Shares Short | 449,002 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$6.33 |
News
See moreYahoo Finance • last month
Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026
Yahoo Finance • 5 months ago
Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules
Yahoo Finance • 5 months ago
Tempest Therapeutics announces $8.35M registered direct offering, concurrent private placement
Yahoo Finance • 5 months ago
Butterfly Network, Citius Pharma Drive Biotech Momentum In After-Hours Trading
About
CEO | Dr. Matthew Angel Ph.D. |
CFO | Mr. Nicholas Maestas |
Address | 2000 Sierra Point Parkway, Brisbane, CA, United States, 94005 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 4 |
